Meyka Pro is live. Get 50% off your first 3 months.Get Started →
Meyka Pro banner
TransMedics Group, Inc.

TransMedics Group, Inc. (TMDX) Stock Overview

Explore TransMedics Group, Inc.’s financial performance, market position, analyst ratings, and future outlook.

TMDX●NASDAQ
HealthcareMedical - Devices
$92.73
$1.79(1.96%)
U.S. Market is Open · 14:47

TransMedics Group, Inc. (TMDX)

Meyka AI Score

Z

Key Financials

Market Cap3.2B
P/E Ratio22.06
EPS (TTM)$1.97
ROE0.28%
Fundamental Analysis

AI Price Forecasts

1 Month$70.13
3 Months$57.85
1 Year Target$101.08

TMDX Stock Analysis & Investment Overview (NASDAQ)

Our AI-powered analysis of TransMedics Group, Inc. (NASDAQ: TMDX) gives investors deep insight into how the stock performs on the NASDAQ exchange, its growth potential, and its market positioning. With a Meyka AI Score of B+, TransMedics Group, Inc.'s NASDAQ-listed shares demonstrate moderate investment characteristics based on our machine learning models.

The current technical analysis of TMDX on the NASDAQ shows an RSI of 66.99, suggesting the stock is in a a neutral condition. Our forecasting models predict a 12-month price target of $101.08 for the NASDAQ listing.

Key metrics behind TransMedics Group, Inc.'s NASDAQ-traded stock include a P/E ratio of 22.06 and a market capitalization of 3.2B. Combined with our AI analysis, these give both institutional and retail investors a clear view of TMDX on the NASDAQ.

Price Performance (NASDAQ: TMDX)

1-Day Change
1.17%
5-Day Change
16.31%
1-Month Change
18.16%
3-Month Change
2.97%
6-Month Change
43.09%
Year-to-Date (YTD) Change
-24.36%
1-Year Change
-24.67%
3-Year Change
54.25%
5-Year Change
241.16%
All-Time (Max) Change
311.49%

Contact Information

https://www.transmedics.com
978 552 0900
200 Minuteman Road, Andover, MA, 01810

Company Facts

8,980 Employees
IPO DateMay 2, 2019
CountryUS
Actively Trading

Frequently Asked Questions